Breakthrough vaccine targets tick-borne bovine anaplasmosis in cattle

University of Missouri researchers are working to develop the first-ever vaccine proven to protect cattle from a devastating tick-borne cattle disease known as bovine anaplasmosis.

Evaluate, a Norstella company, announces acquisition of J+D Forecasting

J+D Forecasting, a leading provider of forecasting solutions for the pharmaceutical industry, is excited to officially share the news of our acquisition by Evaluate, a

January 15, 2024

KFF Health News’ ‘What the Health?’: Live from Aspen: Health and the 2024 elections

The presidential election is less than five months away, and while abortion is the only health policy issue expected to play a leading role, others

June 22, 2024

Filament Health Announces Authorization of Phase 2 Clinical Trial for PEX010 in the Treatment of Methamphetamine Use Disorder | Psychedelic Invest

VANCOUVER, BC, June 3, 2024 /CNW/ – Filament Health Corp. (OTCQB: FLHLF) (Cboe CA: FH) (FSE:7QS) (“Filament” or the “Company“), a clinical‐stage natural psychedelic drug development company, today announced

June 3, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.